Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Clinically Relevant Pharmacokinetic Herb-drug Interactions in Antiretroviral Therapy.

Fasinu PS, Gurley BJ, Walker LA.

Curr Drug Metab. 2015;17(1):52-64. Review.

PMID:
26526838
2.

Effects of notoginsenoside R1 on CYP1A2, CYP2C11, CYP2D1, and CYP3A1/2 activities in rats by cocktail probe drugs.

Yin S, Cheng Y, Li T, Dong M, Zhao H, Liu G.

Pharm Biol. 2016;54(2):231-6. doi: 10.3109/13880209.2015.1029051. Epub 2015 Apr 2.

PMID:
25834921
3.

Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction.

Myers AP, Watson TA, Strock SB.

Pharmacotherapy. 2015 Mar;35(3):e9-e12. doi: 10.1002/phar.1550. Epub 2015 Mar 10.

PMID:
25756365
4.

Interaction between warfarin and Chinese herbal medicines.

Chua YT, Ang XL, Zhong XM, Khoo KS.

Singapore Med J. 2015 Jan;56(1):11-8. Review.

5.

Negligible pharmacokinetic interaction of red ginseng and antihypertensive agent amlodipine in Sprague-Dawley rats.

Ryu SH, Kim JW, Kim YS, Lee SH, Cho YB, Lee HK, Kim YG, Jeong WS, Kim KB.

J Toxicol Environ Health A. 2014;77(22-24):1372-83. doi: 10.1080/15287394.2014.951594.

PMID:
25343287
6.

In vivo distribution and pharmacokinetics of multiple active components from Danshen and Sanqi and their combination via inner ear administration.

Long W, Zhang SC, Wen L, Mu L, Yang F, Chen G.

J Ethnopharmacol. 2014 Oct 28;156:199-208. doi: 10.1016/j.jep.2014.08.041. Epub 2014 Sep 16.

PMID:
25218322
7.

Ginsenoside metabolites inhibit P-glycoprotein in vitro and in situ using three absorption models.

Li N, Wang D, Ge G, Wang X, Liu Y, Yang L.

Planta Med. 2014 Mar;80(4):290-6. doi: 10.1055/s-0033-1360334. Epub 2014 Feb 3.

PMID:
24493631
8.

Drug interactions with phytotherapeutics in oncology.

Haefeli WE, Carls A.

Expert Opin Drug Metab Toxicol. 2014 Mar;10(3):359-77. doi: 10.1517/17425255.2014.873786. Epub 2014 Jan 6. Review.

PMID:
24387348
9.

Ginseng treatment attenuates chronic cyclosporine nephropathy via reducing oxidative stress in an experimental mouse model.

Doh KC, Lim SW, Piao SG, Jin L, Heo SB, Zheng YF, Bae SK, Hwang GH, Min KI, Chung BH, Yang CW.

Am J Nephrol. 2013;37(5):421-33. doi: 10.1159/000349921. Epub 2013 Apr 10.

PMID:
23594788
10.

Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.

Goey AK, Mooiman KD, Beijnen JH, Schellens JH, Meijerman I.

Cancer Treat Rev. 2013 Nov;39(7):773-83. doi: 10.1016/j.ctrv.2012.12.008. Epub 2013 Feb 8. Review.

PMID:
23394826
11.

Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs).

Fang ZZ, Cao YF, Hu CM, Hong M, Sun XY, Ge GB, Liu Y, Zhang YY, Yang L, Sun HZ.

Toxicol Appl Pharmacol. 2013 Mar 1;267(2):149-54. doi: 10.1016/j.taap.2012.12.019. Epub 2013 Jan 7.

PMID:
23306165
12.

Potential serious interactions between nutraceutical ginseng and warfarin in patients with ischemic stroke.

Shao J, Jia L.

Trends Pharmacol Sci. 2013 Feb;34(2):85-6. doi: 10.1016/j.tips.2012.11.008. Epub 2012 Dec 29. No abstract available.

PMID:
23277336
13.

Elevated liver enzymes resulting from an interaction between Raltegravir and Panax ginseng: a case report and brief review.

Mateo-Carrasco H, Gálvez-Contreras MC, Fernández-Ginés FD, Nguyen TV.

Drug Metabol Drug Interact. 2012;27(3):171-5. doi: 10.1515/dmdi-2012-0019. Review.

PMID:
23092794
14.
15.

Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions.

Hermann R, von Richter O.

Planta Med. 2012 Sep;78(13):1458-77. doi: 10.1055/s-0032-1315117. Epub 2012 Aug 1. Review.

16.

The inhibitory effect of 20(S)-protopanaxatriol (ppt) towards UGT1A1 and UGT2B7.

He YJ, Fang ZZ, Ge GB, Jiang P, Jin HZ, Zhang WD, Yang L.

Phytother Res. 2013 Apr;27(4):628-32. doi: 10.1002/ptr.4755. Epub 2012 Jun 27.

PMID:
22736593
17.

Clinical herbal interactions with conventional drugs: from molecules to maladies.

Chen XW, Serag ES, Sneed KB, Liang J, Chew H, Pan SY, Zhou SF.

Curr Med Chem. 2011;18(31):4836-50. Review.

PMID:
21919844
18.

Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) activity in healthy participants.

Malati CY, Robertson SM, Hunt JD, Chairez C, Alfaro RM, Kovacs JA, Penzak SR.

J Clin Pharmacol. 2012 Jun;52(6):932-9. doi: 10.1177/0091270011407194. Epub 2011 Jun 6.

19.

Metabolism of ginseng and its interactions with drugs.

Qi LW, Wang CZ, Du GJ, Zhang ZY, Calway T, Yuan CS.

Curr Drug Metab. 2011 Nov;12(9):818-22. Review.

20.

Deglycosylated ginsenosides are more potent inducers of CYP1A1, CYP1A2 and CYP3A4 expression in HepG2 cells than glycosylated ginsenosides.

Hao M, Ba Q, Yin J, Li J, Zhao Y, Wang H.

Drug Metab Pharmacokinet. 2011;26(2):201-5. Epub 2010 Dec 17.

Supplemental Content

Loading ...
Support Center